1. Should Methotrexate plus Calcineurin Inhibitors Be Considered Standard of Care for Prophylaxis of acute Graft-versus-Host Disease? 
Rainer Storb, Joseph H. Antin, Corey Cutler 
Biology of Blood and Marrow Transplantation 
Volume 16, Issue 1, Pages S18-S27 (January 2010)
DOI: /j.bbmt
Copyright © 2010 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Survival and cGVHD in patients with aplastic anemia (2-63 years old) given HLA matched-related grafts and receiving MTX/CsA after conditioning with cyclophosphamide and antithymocyte globulin (Cy/ATG) [87]. Similar results have been reported in children by Locatelli et al. [88].
Biology of Blood and Marrow Transplantation  , S18-S27DOI: ( /j.bbmt )
Copyright © 2010 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Survival of patients with chronic myelogenous leukemia in chronic phase (CML-CP) given HLA-matched unrelated HCT and receiving MTX/CsA after conditioning with cyclophosphamide and total body irradiation (Cy/TBI) [89]. This represents a subgroup of patients who received prophylaxis with fluconazole and ganciclovir.
Biology of Blood and Marrow Transplantation  , S18-S27DOI: ( /j.bbmt )
Copyright © 2010 American Society for Blood and Marrow Transplantation Terms and Conditions